SkinPen® Wins U.K. Innovation Award

Word has gotten out about the safety and effectiveness of SkinPen®, so much so that our fame is spreading around the world. The United Kingdom-based 2018 microneedling SkinpenAesthetics Award results are in, and Bellus Medical came home with the prize! During a December evening of glitz, glamour, and celebration, the Barry Knapp Award for Product Innovation of the Year, supported by Medical Aesthetic Group, was presented to Bellus for our SkinPen Precision microneedling device.  

The Medical Aesthetics Group presented awards for products launched in the U.K. that showcase genuine innovation or product advancement leading to treatment for new indications, quicker or easier treatments, better treatment outcomes, enhanced patient safety — all backed up by sound evidence. Both the nominations and winner selection for this award were selected by an expert panel of judges.        

The U.K. award follows Bellus’ recent personal best of eight Aesthetics Everything Award wins and SkinPen’s U.S. Food and Drug Administration (FDA) clearance 

“Bellus Medical, in partnership with BioActiveAesthetics, is honored to have received this prestigious award,” said Bellus President Joe Proctor. “SkinPen is a first-in-class technology that delivers safe and effective results. We are thankful to Medical Aesthetics Group for recognizing our innovation in aesthetics.” 

Patient safety is what is most important to us, which is why Bellus partners with the best practices in the industry. If you’re looking for a microneedling treatment, be sure to protect yourself by seeing a medical provider that uses an FDA-cleared device.   

For more information about the award, view our press release. And feel free to share on social media using hashtags #SkinPen, #microneedling, #AestheticsAwards2018 — and tagging SkinPen.  

 

See intended use, important safety information, and clinical trial details (data on file) at skinpen.com.